Insider Selling: DocuSign, Inc. (NASDAQ:DOCU) Insider Sells $1,306,582.14 in Stock

DocuSign, Inc. (NASDAQ:DOCUGet Free Report) insider Robert Chatwani sold 15,706 shares of the company’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total value of $1,306,582.14. Following the sale, the insider now owns 76,842 shares in the company, valued at approximately $6,392,485.98. The trade was a 16.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

DocuSign Price Performance

DOCU opened at $88.06 on Friday. The company has a 50 day simple moving average of $87.54 and a two-hundred day simple moving average of $80.31. The firm has a market cap of $17.79 billion, a P/E ratio of 18.16, a PEG ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.

DocuSign (NASDAQ:DOCUGet Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm had revenue of $776.25 million for the quarter, compared to analysts’ expectations of $760.94 million. During the same period in the previous year, the firm posted $0.76 earnings per share. The business’s revenue was up 9.0% compared to the same quarter last year. Equities analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on DOCU shares. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $90.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Morgan Stanley boosted their price target on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. UBS Group reduced their price objective on DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a report on Friday, March 14th. William Blair raised shares of DocuSign from a “market perform” rating to an “outperform” rating in a report on Monday, March 17th. Finally, HSBC reissued a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, DocuSign presently has a consensus rating of “Hold” and an average target price of $95.00.

Check Out Our Latest Stock Analysis on DOCU

Institutional Investors Weigh In On DocuSign

Several hedge funds and other institutional investors have recently modified their holdings of DOCU. Itau Unibanco Holding S.A. purchased a new position in shares of DocuSign during the third quarter worth approximately $28,000. Kestra Investment Management LLC purchased a new stake in shares of DocuSign during the 4th quarter worth $30,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign during the third quarter valued at about $33,000. Modus Advisors LLC acquired a new stake in DocuSign in the fourth quarter valued at approximately $36,000. Finally, First Horizon Advisors Inc. boosted its position in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares in the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

DocuSign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.